| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000257279.1 |
Gefitinib |
Breast invasive carcinoma |
0.038426366 |
Resistant |
| ENSG00000257279.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.023279052 |
Sensitive |
| ENSG00000257279.1 |
Gefitinib |
Thyroid carcinoma |
0.028323656 |
Sensitive |
